Home › Funds › Caligan Partners LP › VRDN

Caligan Partners LP position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

Caligan Partners LP reported holding 2,193,981 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$40.3M, representing 2.36% of its reported portfolio and ranking #11 among its reported holdings. Caligan Partners LP first reported this position in Q2 2026.

Latest position (Q2 2026)2.19M sh
Reported value held$40.30M
Portfolio Weight2.36%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's VRDN position evolved

Caligan Partners LP first disclosed a stake in VRDN in Q2 2026 at 2,193,981 shares (US$40.3M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.19M $40.30M New

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in VRDN — the largest reported positions include Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has Caligan Partners LP held VRDN?

Caligan Partners LP has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Caligan Partners LP's current position in VRDN?

As of Q2 2026, Caligan Partners LP holds 2.19M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $40.30M, representing 2.36% of its reported portfolio and ranking #11.

Has Caligan Partners LP been buying or selling VRDN?

In the latest 13F filing (Q2 2026), Caligan Partners LP newly opened its position in VRDN.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.